Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesPayablesPreferred Stock LiabilitiesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aimei Health Technology (AFJK) Common Equity (2023 - 2025)

Aimei Health Technology (AFJK) has 3 years of Common Equity data on record, last reported at -$3.4 million in Q3 2025.

  • On a quarterly basis, Common Equity fell 331.61% to -$3.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$3.4 million, a 331.61% decrease, with the full-year FY2024 number at -$1.5 million, down 1000.93% from a year prior.
  • Common Equity reached -$3.4 million in Q3 2025 per AFJK's latest filing, down from -$2.9 million in the prior quarter.
  • Over the last five years, Common Equity for AFJK hit a ceiling of -$134124.0 in Q4 2023 and a floor of -$3.4 million in Q3 2025.
  • A 3-year average of -$1.5 million and a median of -$1.1 million in 2024 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: tumbled 1000.93% in 2024, then plummeted 331.61% in 2025.
  • Tracing AFJK's Common Equity over 3 years: stood at -$134124.0 in 2023, then crashed by 1000.93% to -$1.5 million in 2024, then tumbled by 132.93% to -$3.4 million in 2025.
  • Business Quant data shows Common Equity for AFJK at -$3.4 million in Q3 2025, -$2.9 million in Q2 2025, and -$2.4 million in Q1 2025.